Response to mason and drakeman's commentary on “fishing for sharks: Partner selection in biopharmaceutical R&D alliances” |
| |
| Authors: | Luis Diestre Nandini Rajagopalan |
| |
| Affiliation: | 1. IE Business School, Strategy Department, , Madrid, Spain;2. Marshall School of Business, Management and Organization Department, University of Southern California, , Los Angeles, California, U.S.A. |
| |
| Abstract: | We respond to Mason and Drakeman's comment on our published paper titled “Are All ‘Sharks’ Dangerous? New Biotechnology Ventures and Partner Selection in R&D Alliances” (Diestre and Rajagopalan, 2012). We discuss both their survey analysis and alternative explanation and conclude that neither of them invalidates our theoretical premise and our empirical conclusions. Copyright © 2014 John Wiley & Sons, Ltd. |
| |
| Keywords: | R&D alliances innovation new ventures value creation and value appropriation biopharmaceutical industry |
|
|
